Doug Wilson
Non-Executive Director / AFT Pharmaceuticals
Dr Doug Wilson is a New Zealand medical graduate with postgraduate experience in London at St Thomas Hospital Medical School, and at Walter and Eliza Hall Institute Melbourne.
Dr Wilson joined the international pharmaceutical industry and became senior vice president for Boehringer Ingeleim for Medicine and regulatory affairs in the USA where he was responsible for all dealings with FDA. He moved to Ingelheim and had the same responsibilities worldwide. Dr Wilson headed the company’s international labelling committee, was deputy head of the International Medical Committee which oversaw all drugs in clinical development globally, and saw ten drugs approved in the USA during his tenure.
